-+ 0.00%
-+ 0.00%
-+ 0.00%

SAB Biotherapeutics Enters Sales Agreement With UBS Securities; Co May Offer And Sell From Time To Time Common Stock Of Up To $75M

Benzinga·12/29/2025 21:12:02
Listen to the news

-SEC Filing